Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10
Published July 24, 2024 · Recall initiated: April 30, 2024
Summary
FDA records drug Class II recall D-0602-2024, published July 24, 2024 and initiated April 30, 2024. Recalling firm: Viatris Inc; Status: Completed; Reported quantity: 12,691 bottles; Lot: Lot #: 8147040; Exp. June 2024 Lot #: 8163764; Exp. March 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Viatris Inc
- Distributor
- U.S. Nationwide
- Lot
- Lot #: 8147040; Exp. June 2024 Lot #: 8163764; Exp. March 2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDALevothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b)December 18, 2024
- FDALevothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b)December 18, 2024
- FDAFludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By:July 24, 2024
- FDACardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, DistributedJuly 24, 2024
Questions about this recall
Was Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10 recalled?
Yes. FDA published recall D-0602-2024 on July 24, 2024. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter